Nabla Bio

Innovating antibody design with AI.

Edited:

📋 Overview of Nabla Bio

Founding Year

2020

Estimated Funding

$0000

Size

$0000

Locations

Boston

Primary Industry

Biotechnology

📙 About Nabla Bio

Nabla Bio designs antibodies with atomic precision by integrating AI and experimental technologies. Their approach combines generative models and multiplexed screens to create antibodies against challenging disease targets. It aims to design drugs with superior manufacturability and safety.

💰 Recent Investors of Nabla Bio

Boom Capital Ventures, Cantos Ventures, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.